Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Chemed Inc (CHE)

Chemed Inc (CHE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,611,578
  • Shares Outstanding, K 15,874
  • Annual Sales, $ 1,939 M
  • Annual Income, $ 219,920 K
  • 60-Month Beta 0.67
  • Price/Sales 3.91
  • Price/Cash Flow 27.68
  • Price/Book 11.08

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 3.79
  • Number of Estimates 2
  • High Estimate 4.02
  • Low Estimate 3.55
  • Prior Year 3.36
  • Growth Rate Est. (year over year) +12.80%

Price Performance

See More
Period Period Low Period High Performance
1-Month
411.81 +15.42%
on 05/04/20
489.00 -2.80%
on 05/26/20
+18.47 (+4.04%)
since 04/27/20
3-Month
330.01 +44.03%
on 03/23/20
489.00 -2.80%
on 05/26/20
+34.89 (+7.92%)
since 02/27/20
52-Week
324.31 +46.56%
on 05/29/19
513.75 -7.48%
on 02/19/20
+142.49 (+42.81%)
since 05/24/19

Most Recent Stories

More News
Chemed Corporation to Present at the Jefferies 2020 Virtual Healthcare Conference

Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Jefferies 2020 Virtual Healthcare Conference on Thursday, June 4, 2020, at approximately 9:00 a.m. (ET).

CHE : 475.31 (-0.87%)
The Zacks Analyst Blog Highlights: Brookdale Senior Living, The Ensign Group, Amedysis and Chemed

The Zacks Analyst Blog Highlights: Brookdale Senior Living, The Ensign Group, Amedysis and Chemed

AMED : 182.89 (-2.88%)
BKD : 3.84 (+5.21%)
ENSG : 46.92 (+5.51%)
CHE : 475.31 (-0.87%)
Silver Tsunami to Hit the United States: 4 Stocks in Focus

There are approximately 35 million Americans aged 65 or older currently and this number is expected to double in the next 25 years.

AMED : 182.89 (-2.88%)
BKD : 3.84 (+5.21%)
ENSG : 46.92 (+5.51%)
CHE : 475.31 (-0.87%)
DVA or CHE: Which Is the Better Value Stock Right Now?

DVA vs. CHE: Which Stock Is the Better Value Option?

DVA : 78.71 (+0.88%)
CHE : 475.31 (-0.87%)
Is Chemed (CHE) Stock Outpacing Its Medical Peers This Year?

Is (CHE) Outperforming Other Medical Stocks This Year?

CHE : 475.31 (-0.87%)
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend

Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company's 2020 annual stockholders' meeting. New to the Board are Ron DeLyons, 58, Managing Member and Chief Executive...

CHE : 475.31 (-0.87%)
What Makes Chemed (CHE) a New Buy Stock

Chemed (CHE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CHE : 475.31 (-0.87%)
DVA vs. CHE: Which Stock Should Value Investors Buy Now?

DVA vs. CHE: Which Stock Is the Better Value Option?

DVA : 78.71 (+0.88%)
CHE : 475.31 (-0.87%)
Chemed Corporation to Present at the BofA Securities 2020 Virtual Health Care Conference

Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2020 Virtual Health Care Conference on Tuesday, May 12, 2020, at 3:00 PM (ET).

CHE : 475.31 (-0.87%)
Chemed's (CHE) Q1 Earnings Beat Estimates, Margins Improve

Chemed's (CHE) first-quarter 2020 results reflect strong segmental performances amid the coronavirus-led economic doldrums.

RMD : 153.71 (-4.22%)
CHE : 475.31 (-0.87%)
VRAY : 1.8700 (+6.25%)
APHA : 4.19 (-0.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade CHE with:

Business Summary

Chemed Corporation is the nation's largest provider of end-of-life hospice care services through its VITAS Healthcare Corporation subsidiary. Chemed also maintains a presence in the residential and commercial repair-and-maintenance industry through two subsidiaries. Roto-Rooter is North America's largest...

See More

Key Turning Points

2nd Resistance Point 491.62
1st Resistance Point 483.46
Last Price 475.31
1st Support Level 465.26
2nd Support Level 455.22

See More

52-Week High 513.75
Last Price 475.31
Fibonacci 61.8% 441.38
Fibonacci 50% 419.03
Fibonacci 38.2% 396.68
52-Week Low 324.31

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar